Netherlands calling with a 10% discount on C5's Pharma & Biotech Patent Litigation Conference
The IPKat
MAY 12, 2023
The AmeriKat is particularly looking forward to the session on "Managing the Implications of the EPO's Decisions in BOA Referral G 2/21" and, as ever, her favorite favorite topic - SPCs. This year's session - no surprise - delves into what litigation in the new era of the UPC will look like for pharma and biotech litigation.
Let's personalize your content